Important pharmacy news and late-breaking industry information updated daily.
FDA Commissioner Scott Gottlieb, MD, is being urged to give Congress recommendations on how deal with drug shortages across the United States. A bipartisan group of senators, led by Sens.
JAPhA study: Older patients, patients on more than five medications more likely to have prescribing cascades
Pharmacist and student pharmacist attendees tackle addiction and recovery
FDA approved Thursday the first generic versions of buprenorphine and naloxone (Suboxone—Indivior) sublingual film for the treatment of opioid dependence. Mylan Technologies and Dr. Reddy's Laboratories received FDA approval to market buprenorphine and naloxone sublingual film in multiple strengths.
West Virginia Attorney General Patrick Morrisey is calling on doctors and pharmacists in the state to support a new anti-retaliation law to alleviate any negative consequences for doctors who follow their best medical judgment and refuse to prescribe opioids.
HHS Secretary Alex Azar on Tuesday told the Senate Committee on Health, Education, Labor, and Pensions that several drug companies are looking at "substantial and material" price cuts. He said in testimony before the committee that companies are working with PBMs to make sure "they are not discriminated against" for cutting their prices.
CMS released on Monday guidance that aims to help states leverage Medicaid to fight the opioid crisis.
Program offers multiple opportunities for pharmacy staff to fight diabetes in their communities
Only 2% of nation belongs to Be The Match registry
Pharmacists can serve as important educators